Skip to main content
. 2020 Jun 26;38(31):4877–4884. doi: 10.1016/j.vaccine.2020.04.066

Table 3a.

Enzyme-linked immunospot assay (ELISpot) responses to rVSV ZEBOV vaccination: Distribution of samples with a background (mock stimulus) subtracted Ebola GP response ≥ 10 SFU per million PBMC and > 2x Mock response by time point.

Time point Samples with Ebola GP ≥ 10 (%)
D0 (n = 45) 1(2.2)
D14 (n = 44) 2 (4.5)
D28 (n = 74) 10 (13.5)
D84 (n = 84) 10 (11.9)
D180 (n = 56) 27 (48.2)
Total (n = 303)
Total post-vaccination (n = 258)
50 (16.5)
49 (19.0)